Latest AI and machine learning research in gastroenterology for healthcare professionals.
Probiotic therapeutics are evolving from generalized wellness supplements to precision Live Biotherapeutic Products aimed at specific disease targets. This review elucidates the multi-layered mechanistic framework of probiotic action, which spans ecological niche modulation, epithelial barrier reinforcement, and systemic signaling via the gut-brain axis. While clinical efficacy is established for ...
BACKGROUND: Hepatitis E virus (HEV) infection remains a major cause of liver failure with high short-term mortality, yet predictive models incorporati...
RATIONALE AND OBJECTIVES: The non-invasive biomarkers for predicting progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC) t...
OBJECTIVES: To explore the correlation of tea consumption with risks of gastrointestinal diseases using a risk prediction model integrating interpreta...
PURPOSE: Hypervascular pancreatic ductal adenocarcinoma (PDAC) and mass-forming pancreatitis (MFP) represent a classic diagnostic mimicry on contrast-...
PURPOSE: To develop and validate deep leaning-based machine learning models using longitudinal multi-sequence MRI for predicting treatment response of...
OBJECTIVE: To develop and validate a machine learning model based on quantitative parameters of dual-energy CT (DECT) virtual monoenergetic images (VM...
The fecal immunochemical test (FIT) for detecting fecal occult blood, used alone or in combination with other stool biomarkers, has been demonstrated ...
INTRODUCTION: Blood transfusion in patients undergoing surgical resection for pancreatic ductal adenocarcinoma (PDAC) is associated with worse outcome...
PURPOSE: The purpose of this study was to evaluate the contribution of radiomics features extracted from various pancreatic structures on computed tom...
BACKGROUND: Early diagnosis and accurate prediction of treatment response in esophageal squamous cell carcinoma (ESCC) remain major clinical challenge...
AIMS: Annotation of liver biopsies for disease staging is increasingly aided by digital pathology; however, existing systems do not quantify inflammat...
BACKGROUND: Tumor heterogeneity mediated drug resistance was a core clinical challenge to improve the prognosis of patients with advanced hepatocellul...
Liver cancer ranks sixth in incidence and third in mortality worldwide, with hepatocellular carcinoma (HCC) accounting for 90% of cases. Kinesin famil...
Esophageal squamous cell carcinoma (ESCC) lacks a standardized classification system, resulting in inconsistent clinical management and a suboptimal p...
Postoperative recurrence and metastasis in esophageal squamous cell carcinoma (ESCC) are closely associated with cancer stem cells (CSCs), though the ...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. It is often diagnosed at advanced stages and characterized by high recu...
The rise of AI in healthcare offers major potential for diagnosis and learning but also exposes to a worrying risk of "deskilling." Recent data from c...